Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Cipla Limited
FDA Inspection
•Cipla Limited•September 27, 2019

Cipla Limited – FDA Inspection, Sep 27, 2019

Record Details

This FDA Inspection record concerns Cipla Limited, with an inspection on September 27, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Cipla Limited
Inspection Date
September 27, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • June P. Page (FDA Associated Person)
  • Rajiv R. Srivastava (FDA Associated Person)
  • Thomas J. Arista
View Company Profile

ID · 8e4dda74-73d5-4f2e-853a-19cf3d2511d5

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1103305
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

12
  1. 21 CFR 211.42(c)(10)(vi)Equipment to control conditions
  2. 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
  3. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  4. 21 CFR 211.46(b)Equipment for Environmental Control
  5. 21 CFR 211.63Equipment Design, Size and Location
  6. 21 CFR 211.113(b)Procedures for sterile drug products
  7. 21 CFR 211.113(b)Validation lacking for sterile drug products
  8. 21 CFR 211.100(a)Absence of Written Procedures
  9. 21 CFR 211.192Investigations of discrepancies, failures
  10. 21 CFR 211.160(b)(2)Sampling/testing of in-process materials

Showing 10 of 12 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Cipla Limited

13
DateClassificationOfficeProject area
April 17, 2026Not classifiedOffice of Inspections and InvestigationsDrug Quality Assurance
June 21, 2024VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 26, 2022OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 28, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 28, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 13 other inspections on the company page
Other documents for Cipla Limited
  • FDA Inspection 1313374 - 2026-04-17
  • FDA Inspection 1240813 - 2024-06-21
  • FDA Inspection 1178952 - 2022-08-26
  • FDA Inspection 1078911 - 2019-01-28
  • FDA Inspection 1069950 - 2018-09-28

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cipla Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.